webinar register page

Webinar banner
Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?
Category: BioTech
> Cancer, other rare conditions and vaccines

Moderator:
> Michael Ringel, JD PhD
Managing Director and Senior Partner Global Leader, Growth & Innovation Analytics

Panelists:
> Javad Shahidi, MD, MSc
Vice President, Global Oncology R&D, Daiichi Sankyo
> Flavio Manetlli, MD, PhD
Chief Medical officer, Dompé U.S. Inc.
> Beth-Ann Coller, Ph.D.
Executive Director, Global Clinical Development, Merck & Co., Inc
> Dan Sexton
Strategy Lead, Takeda Pharmaceutical Company Limited
> Bernard Delaey
Regulatory Therapeutic Area Lead, Sanofi

Oct 27, 2020 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register